Drs. Breneman and Rixe Assume New Leadership Positions in the UC Brain Tumor Center

CINCINNATI—John Breneman, MD, has been named Associate Director of the Brain Tumor Center at the University of Cincinnati Gardner Neuroscience Institute, and Olivier Rixe, MD, PhD, has been named Research Director. The positions, which are effective immediately, were announced today by Ronald Warnick, MD, Medical Director of the UC Brain Tumor Center and Chairman of the Mayfield Clinic.

Dr. Breneman (above left), a radiation oncologist, is the Charles M. Barrett Professor of Radiation Oncology and Adjunct Professor of Neurosurgery at UC and Co-Director of the Precision Radiotherapy Center in West Chester, Ohio. Dr. Rixe (above right), a medical neuro-oncologist, is Director of the Experimental Therapeutics Program and Professor of Medicine in the Division of Hematology-Oncology at UC.

“Drs. Breneman and Rixe have been instrumental in the rapid development of the UC Brain Tumor Center, and today’s appointments reflect their important contributions to both clinical care and medical research,” Dr. Warnick said. “The UC Brain Tumor Center would not be where it is today without their energy, intellect and unwavering commitment. With their leadership and vision, we will continue our quest to find a cure for life-threatening brain tumors.”

Drs. Breneman & Rixe will play integral roles in the UC Brain Tumor Center’s recently announced Molecular Therapeutics Program, which is aimed at understanding the biological mechanisms of cancer’s spread to the brain and developing more effective therapies for the condition. A $2 million gift from the Harold C. Schott Foundation and $4.5 million in additional funds from UC’s Departments of Neurosurgery, Radiation Oncology and Internal Medicine (Division of Hematology-Oncology) have been committed to build the interdisciplinary translational research and patient care program, which is dedicated to tackling the growing problem of brain metastasis.

Dr. Breneman, who also serves as Vice-Chair of UC’s Department of Radiation Oncology, graduated from the University of Iowa College of Medicine and performed his residency at UC Health University Hospital. In 2010 he was named Chair of the American Board of Radiology’s Central Nervous System (CNS) Committee. In that capacity he is responsible for creating the CNS section of the board exam for new radiation oncology graduates as well as the Maintenance of Certification exam for current practitioners. He is also an examiner for the CNS section of the oral exam.

Dr. Rixe came to UC in 2009 from the National Cancer Institute in Bethesda, Md., where he was a staff clinician in the Medical Oncology Branch. A native of France, and a longtime Parisian, he taught and conducted cancer research at the renowned Salpetriere Hospital in Paris for eight years prior to coming to the United States. Dr. Rixe graduated from the University of Paris medical school and earned his doctorate in molecular biology at Paris Diderot University. He performed his residency at at Pierre and Marie Curie University in Paris.

Both Drs. Breneman and Rixe are widely published and are currently engaged in several clinical trials. Dr. Warnick was instrumental in the vision and development of the UC Brain Tumor Center, which was launched in 2008, and of the Precision Radiotherapy Center, which opened in 2003. Dr. Warnick, who maintains a busy clinical practice in neurosurgery and radiosurgery, also serves as Co-Director of the Precision Radiotherapy Center.

This entry was posted in Articles. Bookmark the permalink. Both comments and trackbacks are currently closed.

Click Here to learn about our most recent COVID-19 updates including vaccine information, visitor restrictions, testing, and more.